Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine Efficacy and QoL in Seasonal Allergic Rhinitis
NCT00621959Phase 4Completed
- Sponsor
- UCB
- Start
- Mar 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levocetirizine in seasonal allergic rhinitis (SAR) (2 arms), sponsored by UCB. Primary endpoint: Mean 24-hour Reflective Total 5 Symptoms Score at 14 days. Started Mar 2008; status: completed.
02
Drugs
levocetirizine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00621959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621959.